NEVVI Medicare utilization intelligence

← back

Provider profile

WILLIAMS, STEVEN M.D.

Ophthalmology · NPI 1457685331 · MEMPHIS, TN

1
Groups
21
Codes · 2024
41,724
Disclosed services

WILLIAMS, STEVEN is a Ophthalmology in MEMPHIS, TN, a member of 1 medical group, who billed 21 distinct codes to Medicare Part B in 2024.

Groups: MID-SOUTH RETINA ASSOCIATES, LLC (MEMPHIS, TN)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

41,724
disclosed services
21
codes billed to Medicare Part B
Prior year · CY2023 28,129 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg premiumpremium premiumpremium
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg premiumpremium premiumpremium
92134 Imaging of retina premiumpremium premiumpremium
J2781 Injection, pegcetacoplan, intravitreal, 1 mg premiumpremium premiumpremium
67028 Injection of drug into eye premiumpremium premiumpremium
92014 Established patient complete exam of visual system premiumpremium premiumpremium
J2782 Injection, avacincaptad pegol, 0.1 mg premiumpremium premiumpremium
J0177 Injection, aflibercept hd, 1 mg premiumpremium premiumpremium
J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg premiumpremium premiumpremium
J0178 Injection, aflibercept, 1 mg premiumpremium premiumpremium
92012 Established patient problem focused exam of visual system premiumpremium premiumpremium
92004 New patient complete exam of visual system premiumpremium premiumpremium
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg premiumpremium premiumpremium
J9035 Injection, bevacizumab, 10 mg premiumpremium premiumpremium
92235 Exam of retinal blood vessels using a special camera after injection of a dye premiumpremium premiumpremium
67515 Injection of drug or substance into membrane covering eyeball premiumpremium premiumpremium
76512 2d ultrasound scan of eye tissue and structures premiumpremium premiumpremium
67042 Removal of membrane of retina with removal of internal limiting membrane of retina premiumpremium premiumpremium
67036 Removal of eye fluid (vitreous) between lens and retina premiumpremium premiumpremium
67228 Destruction of leaking blood vessels of retina using laser premiumpremium premiumpremium
92083 Exam of visual field with extended testing premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.